Baillie Gifford & CO Sana Biotechnology, Inc. Transaction History

Baillie Gifford & CO

  • $114 Billion
  • Q4 2025

A detailed history of Baillie Gifford & CO transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 6,609,065 shares of SANA stock, worth $26.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,609,065
Previous 11,436,503 42.21%
Holding current value
$26.4 Million
Previous $40.6 Million 35.05%
% of portfolio
0.02%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 23, 2026
SELL
$3.66 - $5.92 $17.7 Million - $28.6 Million
-4,827,438 Reduced 42.21%
6,609,065 $26.4 Million
Q3 2025

Oct 31, 2025
BUY
$2.83 - $5.14 $3.88 Million - $7.05 Million
1,371,775 Added 13.63%
11,436,503 $40.6 Million
Q2 2025

Aug 06, 2025
SELL
$1.34 - $2.97 $169,842 - $376,441
-126,748 Reduced 1.24%
10,064,728 $27.5 Million
Q1 2025

May 07, 2025
SELL
$1.65 - $4.3 $69,460 - $181,017
-42,097 Reduced 0.41%
10,191,476 $17.1 Million
Q4 2024

Jan 31, 2025
SELL
$1.6 - $4.36 $71,217 - $194,067
-44,511 Reduced 0.43%
10,233,573 $16.7 Million
Q3 2024

Nov 05, 2024
SELL
$3.76 - $6.86 $1.1 Million - $2.01 Million
-293,116 Reduced 2.77%
10,278,084 $42.8 Million
Q2 2024

Jul 25, 2024
SELL
$5.23 - $10.44 $444,963 - $888,224
-85,079 Reduced 0.8%
10,571,200 $57.7 Million
Q1 2024

May 01, 2024
BUY
$4.2 - $11.27 $2.13 Million - $5.71 Million
506,262 Added 4.99%
10,656,279 $107 Million
Q4 2023

Jan 26, 2024
SELL
$2.8 - $4.55 $152,202 - $247,328
-54,358 Reduced 0.53%
10,150,017 $41.4 Million
Q3 2023

Nov 13, 2023
SELL
$3.77 - $6.23 $2.38 Million - $3.94 Million
-631,786 Reduced 5.83%
10,204,375 $39.5 Million
Q2 2023

Jul 28, 2023
SELL
$3.22 - $7.53 $131,272 - $306,983
-40,768 Reduced 0.37%
10,836,161 $64.6 Million
Q1 2023

May 03, 2023
BUY
$3.11 - $4.92 $348,948 - $552,033
112,202 Added 1.04%
10,876,929 $35.6 Million
Q4 2022

Jan 24, 2023
SELL
$3.19 - $6.46 $644,408 - $1.3 Million
-202,009 Reduced 1.84%
10,764,727 $42.5 Million
Q3 2022

Oct 27, 2022
SELL
$5.58 - $9.04 $249,571 - $404,323
-44,726 Reduced 0.41%
10,966,736 $65.8 Million
Q2 2022

Aug 08, 2022
SELL
$4.12 - $9.35 $306,523 - $695,630
-74,399 Reduced 0.67%
11,011,462 $70.8 Million
Q1 2022

May 05, 2022
SELL
$5.24 - $15.58 $923,125 - $2.74 Million
-176,169 Reduced 1.56%
11,085,861 $91.6 Million
Q4 2021

Jan 20, 2022
BUY
$15.18 - $23.15 $1.1 Million - $1.67 Million
72,198 Added 0.65%
11,262,030 $174 Million
Q3 2021

Oct 19, 2021
SELL
$16.29 - $25.88 $847,389 - $1.35 Million
-52,019 Reduced 0.46%
11,189,832 $252 Million
Q2 2021

Aug 02, 2021
BUY
$16.65 - $32.14 $20.9 Million - $40.3 Million
1,254,306 Added 12.56%
11,241,851 $221 Million
Q1 2021

May 06, 2021
BUY
$23.04 - $43.5 $230 Million - $434 Million
9,987,545 New
9,987,545 $334 Million

Others Institutions Holding SANA

# of Institutions
197
Shares Held
122M
Call Options Held
194K
Put Options Held
353K
View Full List

About Sana Biotechnology, Inc.

SANA Quotes by TradingView
  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $759M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email